Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, version 2.2019: Featured updates to the NCCN Guidelines Guidelines
| Authors: | Wierda, W. G.; Byrd, J. C.; Abramson, J. S.; Bilgrami, S. F.; Bociek, G.; Brander, D.; Brown, J.; Chanan-Khan, A. A.; Chavez, J. C.; Coutre, S. E.; Davis, R. S.; Fletcher, C. D.; Hill, B.; Kahl, B. S.; Kamdar, M.; Kaplan, L. D.; Khan, N.; Kipps, T. J.; Ma, S.; Malek, S.; Mato, A.; Mosse, C.; Neppalli, V. T.; Shadman, M.; Siddiqi, T.; Stephens, D.; Wagner, N.; Dwyer, M. A.; Sundar, H. |
| Title: | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, version 2.2019: Featured updates to the NCCN Guidelines |
| Abstract: | Chronic lymphocytic leukemia (CLL) is generally characterized by an indolent disease course. Histologic transformation (also known as Richter's transformation) to more aggressive lymphomas, such as diffuse large B-cell lymphoma or Hodgkin lymphoma, occurs in approximately 2% to 10% of patients and is associated with a poor prognosis. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with histologic transformation. Copyright © 2019 by the National Comprehensive Cancer Network. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 17 |
| Issue: | 1 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2019-01-01 |
| Start Page: | 12 |
| End Page: | 20 |
| Language: | English |
| DOI: | 10.6004/jnccn.2019.0002 |
| PUBMED: | 30659125 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 February 2019 -- Source: Scopus |
